A new drug therapy for three months is showing great promise in returning patients with type 1 diabetes to insulin independence.
Read More »Diabetes In Control
Researchers Develop Successful Insulin-Cell Transplants for Type 1 Diabetics
Researchers at Johns Hopkins have found a way to overcome a major stumbling block to developing successful insulin-cell transplants for people with type I diabetes.
Read More »No Diet Foods for Kids-Can Lead to Obesity
A new study reveals low-calorie foods and drinks made to taste like high-calorie foods and drinks may actually lead to overeating and obesity. If you hope to curb the obesity epidemic in your children, don’t feed them diet foods or drinks.
Read More »Top-10 Comparison of Diabetes Drugs Give One a Top Grade by Johns Hopkins
A type 2 diabetes drug taken orally and in widespread use for more than a decade has been found to have distinct advantages over nine other, mostly newer medications used to control the chronic disease, according to a study by researchers at Johns Hopkins.
Read More »Secondary Failure of Glucose Control With Metformin, Sulfonylurea, or TZD’s Monotherapy
Which drugs are the ones to sustain good control, the longest?
Read More »Metformin and Body Weight
Where most other diabetes medications cause weight gain, metformin can cause weight reduction.
Read More »Takeda Responds to the FDA Advisory Committee Recommendation
Takeda Responds to the FDA Advisory Committee Recommendation: With all the publicity about TZD’s and the cardiovascular ischemic/thrombotic risks the Drug Safety and Risk Management Advisory Committees to the U.S. Food and Drug Administration (FDA) made some blanket statements about all drugs in the class. Takeda makers of Actos, responded …
Read More »Book Review: Living With Diabetes
I recently received a book for review. Living With Diabetes: A Guide For Patients and Parents by James W Reed, M.D., M.A.C.P., F.A.C.E.; and Agiua Heath, M.D.. I had my Dr. of Pharmacy candidate James Wengard review the book. James can offer great feedback as he just spent the last …
Read More »The Final Word on Avandia: Diabetes Drug Should Stay Despite Heart Risks
FDA panel says Avandia offers benefits to people with type 2 disease, but…..
Read More »Statin Use in Patients With LDL’s of 40mg/dL or Less is Safe and Beneficial
Statins used in patients with extremely low LDL cholesterol levels are safe and may lead to improved survival, according to the results of a new study. This survival benefit of a reduced mortality of 42% was observed across multiple subgroups, including patients with LDL cholesterol levels
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.